Comments
Loading...

Arcus Biosciences (RCUS) Stock Price, Quote, News & History

RCUSNYSE
Logo brought to you by Benzinga Data
$21.80
0.010.05%
At close: Jan 15, 4:00 PM EST
$21.69
-0.1-0.46%
Pre-Market: 7:32 AM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-462.00M
Investing Cash Flow (TTM)
299.00M
Financing Cash Flow (TTM)
200.00M
Free Cash Flow (TTM)
-464.00M
Capital Expenditure (TTM)
-2.00M
Net Change in Cash (TTM)
37.00M

Analyst Trends and Forecast

2
Aug 25
5
1
Oct 25
1
Nov 25
1
Dec 25
1
1
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.98B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
9.14
PB Ratio (TTM)
6.19
Earnings Yield % (TTM)
-15.69%
Earnings Yield % (FWD)
-17.75%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.52

Company Debt

Total Debt
$98.00M
LT Debt
$98.00M
LT Debt Issuance (TTM)
$49.00M
LT Debt Repayment (TTM)
-
Total Cash
$238.00M
Debt to Equity
0.25
Issuance of Debt (TTM)
$49.00M
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$21.80
Volume / Avg.
4.07K / 1.91M
Day Range
- - -
52 Wk Range
6.50 - 26.40
Market Cap
$2.68B
P/E Ratio
-
Dividend Yield
-
Exchange
NYSE
RSI
46
Short Interest
11.04%
Days to Cover
5.61

About

Sector
Health Care
Industry
Biotechnology
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RCUS
IDYA

FAQ

Q

How do I buy Arcus Biosciences (RCUS) stock?

A

You can purchase shares of Arcus Biosciences (NYSE:RCUS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Arcus Biosciences (RCUS) competitors?

Q

What is the forecast, or price target, for Arcus Biosciences (RCUS) stock?

A

Arcus Biosciences has a consensus price target of $34.77.

Q

What is the current price for Arcus Biosciences (RCUS)?

A

The stock price for Arcus Biosciences (NYSE: RCUS) is $21.69 last updated January 20, 2026 at 6:41 AM EST.

Q

Does Arcus Biosciences (RCUS) pay a dividend?

A

There are no upcoming dividends for Arcus Biosciences.

Q

When is Arcus Biosciences (NYSE:RCUS) reporting earnings?

A

Arcus Biosciences does not have any upcoming earnings scheduled.

Q

Is Arcus Biosciences (RCUS) going to split?

A

There is no upcoming split for Arcus Biosciences.

Q

What sector and industry does Arcus Biosciences (RCUS) operate in?

A

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.